Search Within

Alexander Noor Shoushtari

Formats
  1. Journal Article (113)
  2. Meeting Abstract (106)
  3. Research Letter (11)
  4. Editorial (7)
  5. Review (4)
  6. Book Section (3)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (246)
  2. Hematologic Malignancies, Division of (246)
  3. Melanoma Disease Management Team (246)
  4. Melanoma and Immunotherapeutics Service (246)
  5. Solid Tumor Oncology Division (246)
  6. GSK Faculty (87)

More Groups

People
  1. Michael Postow (63)
  2. Jedd Wolchok (49)
  3. Margaret Callahan (45)
  4. Paul Chapman (45)
  5. Katherine Panageas (35)
  6. Parisa Momtaz (32)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (25)
  4. 2022 (38)
  5. 2021 (38)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Annals of Oncology (22)
  3. Journal for ImmunoTherapy of Cancer (17)
  4. Clinical Cancer Research (11)
  5. Cancer Research (7)
  6. Melanoma Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. Oxford University Press (29)
  3. American Association for Cancer Research (21)
  4. Biomed Central Ltd (21)
  5. Nature Publishing Group (15)
  6. Elsevier Inc. (13)

More Publishers

Results (246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • More than just skin-deep: A review of imaging’s role in guiding CAR T-cell therapy for advanced melanoma
    Review

    Prendergast, C. M.; Capaccione, K. M.; Lopci, E.; Das, J. P.; Shoushtari, A. N.; Yeh, R.; Amin, D.; Dercle, L.; De Jong, D.
    Diagnostics (2023)

    Fulltext@MSK | Save
  • Factors associated with improved overall survival for patients undergoing embolization of metastatic melanoma
    Meeting Abstract

    Haghani, L.; Zhan, C.; Yarmohammadi, H.; Ziv, E.; Cornelis, F.; Gonzalez Aguirre, A.; Moussa, A.; Santos, E.; Shoushtari, A.; Erinjeri, J.
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save
  • Pilot study of ONCOS-102 and pembrolizumab: Remodeling of the tumor microenvironment and clinical outcomes in anti-PD-1-resistant advanced melanoma
    Journal Article

    Shoushtari, A. N.; Olszanski, A. J.; Nyakas, M.; Hornyak, T. J.; Wolchok, J. D.; Levitsky, V.; Kuryk, L.; Hansen, T. B.; Jäderberg, M.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Repeat dosing of oncolytic adenovirus ONCOS-102 is associated with enhanced and persistent immune responses and improved systemic activity in anti-PD-1 resistant/refractory (R/R) melanoma
    Meeting Abstract

    Shoushtari, A.; Ottesen, L.; Levitsky, V.; Hansen, T. B.; Hornyak, T.; Olszanski, A.; Nyakas, M.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Examining the impact of chromosomal instability on mucosal melanoma tumor infiltrate and responses to PD-1 based therapy
    Meeting Abstract

    Armstrong, E.; Gottesdiener, L.; Schultz, N.; Bakhoum, S. F.; Hollmann, T. J.; Shoushtari, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Modulation of immune gene expression by intra-tumoral oncolytic adenovirus ONCOS-102 is associated with clinical response in anti-PD-1 refractory/resistant melanoma
    Meeting Abstract

    Wiklund, E. D.; Kuryk, L.; Kumar, S.; Jaderberg, M.; Levitsky, V.; Hansen, T. B.; Moller, A. S.; Shoushtari, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase II study of multiple LXH254 drug combinations in patients (pts) with unresectable/metastatic, BRAF V600-or NRAS-mutant melanoma
    Meeting Abstract

    Lebbe, C.; Long, G. V.; Robert, C.; Hamid, O.; Atkinson, V. G.; Shoushtari, A. N.; Daud, A.; Bechter, O. E.; Schadendorf, D.; Sullivan, R. J.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survivors on tebentafusp in phase II trial of previously treated patients with metastatic uveal melanoma
    Meeting Abstract

    Sato, T.; Ikeguchi, A. P.; Nathan, P.; Carvajal, R. D.; Shoushtari, A. N.; Gajewski, T. F.; Hassel, J. C.; Rioth, M.; Leyvraz, S.; Daniels, G. A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of infrequent tebentafusp treatment omissions in patients with metastatic uveal melanoma
    Meeting Abstract

    Schlaak, M.; Dummer, R.; Kirkwood, J. M.; Joshua, A.; Milhem, M.; Gastaud, L.; Mauch, C.; Yushak, M. L.; Lockwood, S.; Hayes, C.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • A propensity score weighted comparison of tebentafusp or pembrolizumab versus combination ipilimumab and nivolumab in untreated metastatic uveal melanoma
    Meeting Abstract

    Piulats Rodriguez, J. M.; Piperno-Neumann, S.; Rutkowski, P.; Nathan, P.; Hassel, J. C.; Espinosa, E.; de la Cruz Merino, L.; Ochsenreither, S.; Shoushtari, A. N.; Orloff, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save